Immunohistochemistry (IHC)
(Formalin-fixed, paraffin-embedded human Gastric Carcinoma stained with CA19-9 Recombinant Rabbit Monoclonal Antibody (CA19.9/1390R))
Rabbit anti-Human CA19-9/Sialyl Lewisa (GI Tumor Marker) Antibody | anti-CA19-9 antibody
CA19-9/Sialyl Lewisa (GI Tumor Marker) Recombinant Rabbit Monoclonal Antibody [Clone CA19.9/1390R]
Reactivity
Human
Applications
Flow Cytometry, Functional Assay, Immunofluorescence, Immunohistochemistry
Synonyms
CA19-9/Sialyl Lewisa (GI Tumor Marker); CA19-9/Sialyl Lewisa (GI Tumor Marker) Recombinant Rabbit Monoclonal Antibody [Clone CA19.9/1390R]; CA19.9; Ovarian tumor antigen; Pancreatic tumor antigen; Sialyl Lewis a; anti-CA19-9 antibody
Host
Rabbit
Reactivity
Human
Isotype
IgG, kappa
Clone Number
CA19.9/1390R
Specificity
CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is excellent for staining of formalin-fixed, paraffin-embedded tissues.
Form/Format
200ug/ml of Ab purified by Protein A column. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA and Azide at 1.0mg/ml.
Applicable Applications for anti-CA19-9 antibody
Flow Cytometry (FC/FACS); Immunofluorescence (IF); Immunohistochemistry (IHC)
Application Notes
Flow Cytometry (0.5-1ug/million cells)
Immunofluorescence (0.5-1ug/ml)
Immunohistology (Formalin-fixed) (5-10ug/ml for 30 minutes at RT) (Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)
Immunofluorescence (0.5-1ug/ml)
Immunohistology (Formalin-fixed) (5-10ug/ml for 30 minutes at RT) (Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)
Immunogen
Purified human CA19-9 protein
Cellular Localization
Cytoplasmic
Positive Control
Stomach or Colon Carcinoma
Immunohistochemistry (IHC)
(Formalin-fixed, paraffin-embedded human Gastric Carcinoma stained with CA19-9 Recombinant Rabbit Monoclonal Antibody (CA19.9/1390R))
Immunohistochemistry (IHC)
(Formalin-fixed, paraffin-embedded human Gastric Carcinoma stained with CA19-9 Recombinant Rabbit Monoclonal Antibody (CA19.9/1390R))
Similar Products
Product Notes
The CA19-9 (Catalog #AAA439994) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The CA19-9/Sialyl Lewisa (GI Tumor Marker) Recombinant Rabbit Monoclonal Antibody [Clone CA19.9/1390R] reacts with Human and may cross-react with other species as described in the data sheet. AAA Biotech's CA19-9/Sialyl Lewisa (GI Tumor Marker) can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS); Immunofluorescence (IF); Immunohistochemistry (IHC). Flow Cytometry (0.5-1ug/million cells) Immunofluorescence (0.5-1ug/ml) Immunohistology (Formalin-fixed) (5-10ug/ml for 30 minutes at RT) (Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes). Researchers should empirically determine the suitability of the CA19-9 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "CA19-9/Sialyl Lewisa (GI Tumor Marker), Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
